Hydroxyurea (HU) supresses the growth of CML cells expressing BCR/ABLT315I in heavily pretreated patients and synergizes with ponatinib in inhibiting the proliferation of CML cells in vitro
ONCOLOGY RESEARCH AND TREATMENT（2015）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要